Literature DB >> 12193922

Laparoscopic radical hysterectomy (type III) with aortic and pelvic lymphadenectomy in patients with stage I cervical cancer: surgical morbidity and intermediate follow-up.

Nick M Spirtos1, Scott M Eisenkop, John B Schlaerth, Samuel C Ballon.   

Abstract

OBJECTIVE: The purpose of this study was to determine the risk of recurrence and to quantify morbidity and mortality rates in patients with cervical cancer who consented to undergo laparoscopic radical hysterectomy (type III) and retroperitoneal lymphadenectomy. STUDY
DESIGN: Seventy-eight consecutive patients with stage IA(2) and IB cervical cancer with at least 3 years of follow-up consented to undergo this surgical procedure with argon beam coagulation and endoscopic staplers. All patients had a Quetelet index of <35. The average age was 41.5 years (range, 26-62 years). Sixty-eight patients had squamous cell carcinomas; 8 patients had adenocarcinomas, and 2 patients had adenosquamous carcinomas of the cervix.
RESULTS: All but 5 surgical procedures were completed laparoscopically. The average operative time was 205 minutes (range, 150-430 minutes). The average blood loss was 225 mL (range, 50-700 mL). One patient (1.3%) had transfusion. Operative cystotomies occurred for 3 patients: 2 cystotomies were repaired laparoscopically, and 1 cystotomy required laparotomy. One patient underwent laparotomy because of equipment failure, and another patient underwent laparotomy to pass a ureteral stent. Two other patients underwent laparotomy to control bleeding sites. The average lymph node count was 34 (range, 19-68). Nine patients (11.5%) had positive lymph nodes. All surgical margins were macroscopically negative, but 3 patients had microscopically positive and/or close surgical margins. One patient had a ureterovaginal fistula after the operation that required reoperation. Follow-up has been provided every 3 months. There have been 4 documented recurrences (5.1%), with a minimum of 3 years of follow-up.
CONCLUSION: Laparoscopic radical hysterectomy (type III) can be successfully completed in patients with early-stage cervical cancer with acceptable morbidity. Intermediate-term follow-up validates the adequacy of this procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12193922     DOI: 10.1067/mob.2002.123035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  32 in total

1.  Total laparoscopic radical hysterectomy for treatment of uterine malignant tumors: analysis of short-term therapeutic efficacy.

Authors:  Yi Shen; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

2.  Urologic complications of laparoscopic radical hysterectomy and lymphadenectomy.

Authors:  Jong Ha Hwang; Myong Cheol Lim; Jae Young Joung; Sang-Soo Seo; Sokbom Kang; Ho Kyung Seo; Jinsoo Chung; Sang-Yoon Park
Journal:  Int Urogynecol J       Date:  2012-04-25       Impact factor: 2.894

Review 3.  Nerve-sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa).

Authors:  Chumnan Kietpeerakool; Apiwat Aue-Aungkul; Khadra Galaal; Chetta Ngamjarus; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

4.  Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.

Authors:  Andreas Kavallaris; Nektarios Chalvatzas; Antonios Gkoutzioulis; Dimitrios Zygouris
Journal:  Arch Gynecol Obstet       Date:  2020-10-17       Impact factor: 2.344

5.  Comparison of a novel surgical approach for radical hysterectomy: robotic assistance versus open surgery.

Authors:  Gerald Feuer; Benedict Benigno; Lindal Krige; Patricia Alvarez
Journal:  J Robot Surg       Date:  2009-10-09

Review 6.  Early cervical neoplasia: advances in screening and treatment modalities.

Authors:  Brent Tierney; Shannon N Westin; Matthew P Schlumbrecht; Pedro T Ramirez
Journal:  Clin Adv Hematol Oncol       Date:  2010-08

7.  Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity.

Authors:  Arne Gruen; Thabea Musik; Christhardt Köhler; Jürgen Füller; Thomas Wendt; Carmen Stromberger; Volker Budach; Achim Schneider; Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

Review 8.  Innovative laparoscopic surgery in gynecologic oncology.

Authors:  Siobhan M Kehoe; Pedro T Ramirez; Nadeem R Abu-Rustum
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

9.  Comparative evaluation of surgical stress of laparoscopically assisted vaginal radical hysterectomy and lymphadenectomy and laparotomy for early-stage cervical cancer.

Authors:  Cai-Ying Hou; Xiu-Li Li; Feng Jiang; Rong Jie Gong; Xin Yu Guo; Yuan-Qing Yao
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

10.  Complications of laparoscopic radical hysterectomy and lymphadenectomy for invasive cervical cancer: experience based on 317 procedures.

Authors:  H Xu; Y Chen; Y Li; Q Zhang; D Wang; Z Liang
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.